ArticleCell death & disease2021

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors.

Konstantinos V Floros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.